TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Escherichia coli (strain K12))
X-Biotix Therapeutics
US Patent
X-Biotix Therapeutics
US Patent
Affinity DataIC50: 1.50E+3nMAssay Description:Dilutions of test compound were pre-incubated with 5 nM P. aeruginosa or E. coli LpxC for 10 minutes at room temperature in 50 mM NaH2PO4, 500 mM suc...More data for this Ligand-Target Pair

3D Structure (crystal)